The short answer: women can physically take sildenafil, and in a few specific medical situations doctors do prescribe it to women, but it is not licensed in the UK for sexual problems in women and the evidence that it helps them is weak. Sildenafil works by improving blood flow in response to arousal, which is exactly the right mechanism for erectile dysfunction in men and largely the wrong one for the sexual difficulties women most commonly report. This article explains what the research actually found, when sildenafil is legitimately prescribed to women, and what helps with low desire and arousal instead.
What sildenafil is licensed for
In the UK, sildenafil carries two licences. The familiar one is for erectile dysfunction in adult men, where it is taken before sex to support an erection in response to stimulation. The second, less known licence, at different doses and under specialist supervision, is for pulmonary arterial hypertension, a condition of raised blood pressure in the vessels of the lungs, and that licence covers women as well as men. The NHS medicine information on sildenafil reflects both uses. What does not exist, in the UK or anywhere else, is a licence for sildenafil as a treatment for low desire, arousal difficulties or orgasm problems in women. That is not an oversight; it reflects what the trials found.
What happened when sildenafil was trialled in women
After sildenafil transformed the treatment of erectile dysfunction in the late 1990s, the manufacturer ran a substantial research programme testing it in women, on the reasonable-sounding theory that if it improves genital blood flow in men, it should do the same in women. In a narrow sense it did: studies measured increased genital blood flow and lubrication. The problem was that this rarely translated into women feeling more desire, more aroused or more satisfied. Large placebo-controlled trials in women found inconsistent, mostly unconvincing results, and the development programme for female sexual dysfunction was stopped in 2004. The lesson researchers drew is now well accepted: in most women with sexual difficulties, the limiting factor is not blood flow to the genitals but desire and arousal at the level of the brain, alongside hormones, relationships, mood and medicines.
There is one caveat worth knowing about. Small studies suggest a possible role for sildenafil in a narrow group: women whose arousal difficulties are caused by antidepressant medicines, particularly SSRIs, where the machinery of desire is intact but the physical response is dampened by the drug. Even there, the evidence is thin and UK prescribers rarely use it; adjusting the antidepressant is usually the better route.
When women are legitimately prescribed sildenafil
Seeing sildenafil on a woman's prescription is not an error. Beyond the pulmonary hypertension licence, specialists sometimes prescribe it off-label for Raynaud's phenomenon, where fingers and toes lose circulation in the cold, and in certain fertility and pregnancy-related contexts under close supervision. These uses have nothing to do with sexual function; they use the same blood-vessel-relaxing mechanism for different ends. Off-label prescribing by a specialist who knows the evidence is a normal, regulated part of UK medicine.
What actually helps women with low desire or arousal
The honest starting point is that female sexual difficulty usually has more than one cause, and the effective treatments target the cause rather than the plumbing. Hormonal changes matter a great deal: falling oestrogen through perimenopause and menopause causes vaginal dryness and discomfort that makes sex painful, and local vaginal oestrogen or HRT treats that directly and well. Testosterone also plays a part in desire for women, and UK menopause specialists sometimes prescribe it off-label for low libido after menopause when HRT alone has not helped; we cover the hormone side in testosterone and libido.
Medicines are the next place to look. Antidepressants commonly dampen desire and arousal in women just as in men, and so can some blood pressure medicines and hormonal contraceptives. Mood, stress, sleep and relationship strain all lower desire, which is why psychological and couples-focused approaches have some of the better evidence in this area. UK guidance, reflected in the NICE Clinical Knowledge Summary on menopause, treats sexual difficulty as something to assess properly, covering hormones, medicines, physical comfort and psychological factors, rather than something to medicate with a single tablet.
Why the male and female situations differ
It can seem unfair that men have a well-evidenced tablet and women do not, but the asymmetry follows from the biology of the problems, not from effort or neglect. Erectile dysfunction is, at root, frequently a blood-flow problem, so a blood-flow medicine fits it; even in men, though, psychological factors are often in the mix and tablets do not fix those either. The sexual difficulties women most often report, low desire, difficulty becoming aroused, discomfort, are distributed across hormones, the nervous system, medicines and life context. No single mechanism means no single tablet, and treatments work best when they are matched to the actual cause.
The sensible next step
If sex has become less wanted, less comfortable or less satisfying, start with a GP, or a menopause specialist if you are in your forties or beyond, and expect a proper conversation rather than a prescription reflex. Useful things to mention: any medicines you take, your cycle or menopause stage, pain or dryness, mood and sleep, and how your relationship is doing. Every one of those threads has options attached. What the evidence does not support is sildenafil as a shortcut for women, and a regulated UK clinician will tell you the same.
